For research teamsHelp me find a study
Back to all studies
Not recruitingEUCTR 2021-000472-11

A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Eating disorders, Binge Eating disorders (BED)Drug

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Need help deciding?

Ask HopeStage to help me review this study

This study may no longer be open, but we can help you understand it and find similar studies.

Loading the security check...
Study ID: EUCTR 2021-000472-11. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

View the historical EU CTR record

View the current CTIS record

Current CTIS country statuses
Historical EU CTR country statuses
  • France : Trial now transitioned

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 7 sites
  • CHU Dijon Bourgogne Hôpital François Mitterand — Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition
    Dijon
    Country status: Not recruiting
  • Centre Hospitalier Universitaire De Montpellier — Nutrition – Diabète
    Montpellier
    Country status: Not recruiting
  • Assistance Publique Hopitaux De Paris — Nutrition
    Paris Cedex 13
    Country status: Not recruiting
  • Centre Hospitalier Universitaire De Bordeaux — Endocrinologie, Diabétologie, Maladies Métaboliques et Nutrition
    Pessac
    Country status: Not recruiting
  • Centre Hospitalier Lyon Sud — Endocrinologie - Diabète - Nutrition
    Pierre Benite
    Country status: Not recruiting
  • CHU De Rouen — Nutrition Clinique
    Rouen Cedex
    Country status: Not recruiting
  • CHRU De Nancy — Endocrinologie, Diabétologie et de Nutrition
    Vandoeuvre Les Nancy
    Country status: Not recruiting
Spain · 6 sites
  • Hospital Universitario de Vall d'Hebrón — Psychiatry
    Bacelona
    Country status: Not recruiting
  • Hospital Germans Trias i Pujol — Psychiatry
    Badalona
    Country status: Not recruiting
  • Hospital Universitario de Vall d'Hebrón- Departamento Digestivo — Digestive
    Barcelona
    Country status: Not recruiting
  • Hospital Universitario Fundación Jiménez Díaz — Endocrinology and nutrition
    Madrid
    Country status: Not recruiting
  • Hospital Universitario Ramón y Cajal — Psychiatry
    Madrid
    Country status: Not recruiting
  • Hospital Universitario Doctor Peset — Psychiatry and Medical Psychology
    Valencia
    Country status: Not recruiting
In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

What to expect

Your next step

Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
66
Sponsor
BIOPROJET PHARMA
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
France, Spain
Age range
Not clearly listed
Official registry ID
EUCTR 2021-000472-11
Official title
A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder
Official source
Official registry link

Ask HopeStage to help me review this study

This study may no longer be open, but we can help you understand it and find similar studies.

Loading the security check...
Study ID: EUCTR 2021-000472-11. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.